MedPath

Total Cardiac Care: a smartphone-based remote monitoring system for Heart Failure Patients

Not Applicable
Conditions
heart failure
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12620000888965
Lead Sponsor
Prince of Wales Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

•Patient who is under the care of, or newly referred to, the community heart failure service at one of the three involved hospitals OR a patient with heart failure who is directly referred to the research team by the treating cardiologist.
•Patient owns a smartphone or iPad that has the capability to operate the TCC application
•Age over 18 years
•Able to provide written informed consent

Exclusion Criteria

•Inability to use the TCC app and peripheral devices due to reasons including but not limited to:
oCognitive impairment
oImpaired dexterity to operate the app
oVisual impairment that would not allow adequate operation of the app
•Lack of fluency with English language

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A process evaluation comprised of four separate primary endpoints is the overall aim. The first part of process evaluation will be assessed by quantification of how many potential participants were eligible to participate, and how many were recruited, this will be collected from medical records<br>[At the completion of the trial (when all participants have been enrolled for 6 months)];To determine app engagement (based on log ins, daily entries for each category of parameter being assessed, additional notes by patients).[At the completion of the trial (all participants enrolled for six months)];Documentation of nature and prevalence of alerts, and the management of each. Each alert will be documented in a study database. This endpoint is considered a composite primary outcome. [Completion of the trial - when all participants have completed the trial (i.e. all participants have been part of the trial for six months). ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath